Vystar Corporation Summary

Company Overview

Vystar Corporation is a Massachusetts-based company involved in the development, production, and marketing of innovative, eco-friendly products for the home, office, and medical sectors.

Key Business Segments

1. Vytex Natural Rubber Latex (NRL)

• Technology: Creator and exclusive owner of multi-patented Vytex NRL technology.
• Product: Reduces antigenic and total protein levels in natural rubber latex to virtually undetectable levels.
• Applications: Used in over 40,000 products including medical gloves, condoms, balloons, foams, adhesives, textiles, paints, protective equipment, sporting goods, and bedding products like mattresses, toppers, and pillows.
• Market Strategy: Expanding into consumer bedding and furniture with label “made with Vytex NRL”.

2. RXAIR - Air Purification Systems

• Product Line:
  • RXair™ Residential Filterless Air Purifier
  • RX400™ FDA-cleared Class II Medical Device
  • RX3000™ Commercial FDA-cleared Class II Device (not currently in production)
• Technology: Uses high-intensity germicidal UV lamps to destroy over 99% of airborne bacteria and viruses on the first pass.
• Certifications: All FDA Class II medical devices, independently tested by EPA and FDA labs, proven to kill germs, viruses, and bacteria.
• Sales Channels: Sold online, via distributors, healthcare and medical markets, retail, and third-party wholesalers.
• Market Focus: Addresses the indoor air quality industry, especially in response to increased demand for air purification amid airborne disease concerns.

3. Fluid Energy Conversion (FEC)

• Technology: Focuses on green energy, harnessing vortex effects, cavitation, and fluid flow phenomena.
• Applications: Mainly water energy solutions; also working on combustion energy applications.
• Background: Over 50 years of research, over 20 patents, developed products that are cost-effective, simple, and high-performing.

Business Acquisitions

• UV Flu Technologies (2018): Founded the RxAir division, producing UV light air purification technology.
• NHS Holdings (2018): To develop and distribute Vytex latex products in the U.S.
• Fluid Energy Conversion Inc. (2019): Acquired majority stake to enhance energy and water applications.
• Murida Furniture (2019): 58% stake, but closed in 2022.

Financial Highlights (2024)

• Revenue: $135,969 (down from $525,883 in 2023, primarily due to inventory and sales allowance adjustments).
• Gross Profit: $69,641 (significantly lower than $384,583 in 2023).
• Net Income: $2,520,312 (a substantial turnaround from a net loss of $8,319,395 in 2023, driven mainly by discontinued operations gains and settlement of liabilities).
• Employees: As of December 31, 2024, the company had 1 employee.
• Market Capitalization: Approximately $90,142 based on shares held by non-affiliates as of June 30, 2024.
• Shares Outstanding: As of April 11, 2025, there are 17,400,614 shares of common stock outstanding.

Additional Notes

• Company is classified as a "smaller reporting company" and is a "reporting company" but has no securities registered on a major national exchange.
• No dividends are paid or expected in the foreseeable future.
• The company relies heavily on private placements, stock-based compensation, and debt instruments for funding due to limited cash flow.
• Discontinued operations include Rotmans Furniture, which closed in late 2022, with assets and liabilities disposed of in early 2024.

Summary: Vystar develops patented natural rubber latex (Vytex), eco-friendly products, medical and consumer air purifiers (RXAIR), and advanced fluidic energy technologies (FEC). It has a small workforce, minimal revenue, but a significant patent portfolio and a focus on expanding its Vytex market applications and air purification solutions.